Nurse take care of oncology patient

Protect your patients.
3M™ solutions for
Oncology care.

3M makes delivering oncology care easier for you and safer for your patients.

Protect your patients.
3M™ solutions for
Oncology care.

3M makes delivering oncology care easier for you and safer for your patients.

Request a trial

When oncology patients count on you, you can count on 3M™ science.

Making the cancer journey safer for patients.

Most cancer treatment is delivered through vascular access devices (VADs). While vascular catheters provide the advantage of prolonged venous access, they also present a risk of complications, especially catheter-related bloodstream infections (CRBSIs).
From preparing a vascular access insertion to securing devices and protecting the skin around them, 3M is your trusted partner, surrounding you with evidence-based solutions so you can deliver the best possible care.  

Choose the right catheter dressing solution for the best patient care.

Every I.V. site presents the potential for infection, dislodgment, skin damage and other complications. These complications can potentially cause patient discomfort and pain, delayed treatments, extended hospital stays, additional therapy, surgical intervention – even increased patient mortality.
3M solutions help you to deliver safer care for oncology patients.

  • Improve your patients‘ outcome by chosing the right I.V. dressing, check out for our new Oncology I.V. dressing selection guide. 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressings is the only transparent securement dressing proven to reduce CRBSI and vascular catheter colonisation that aligns with evidence-based guidelines and practice standards, and provides immediate antimicrobial action upon application to skin.

  • Vascular Access Devices (VAD's) used for oncology treatments come in a variety of forms. 3M™ Tegaderm™ I.V. Dressings and 3M™ Curos™ Disinfecting Caps provide VAD's with antimicrobial protection from extraluminal and intraluminal contamination.


  • Clinical Evidence

    Oncology patients are frequently requiring long term I.V. access. Due to disease and treatment specifics they are often immunosuppressed and this makes them more prone to infections including catheter related bloodstream infections (CRBSIs).¹

    In this clinical summary we explore the evidence related to the overall CRBSI burden and infection risk related to different vascular access devices (VADs), use of CHG impregnated dressings as well as disinfecting caps to help improve clinical outcomes in oncology patients and review latest international recommendations.

  • Free webinar on demand

    Learn more about “CRBSI prevention: Addressing clinical challenges with catheter maintenance – focus on Oncology patients”.

green gradient banner

Protect your patient.
3M solutions for Oncology care.

3M infection prevention solutions help you spend more time caring for your patients and less time worrying about complications.  

Protect your patient.
3M solutions for Oncology care.

3M infection prevention solutions help you spend more time caring for your patients and less time worrying about complications.  

REQUEST A TRIAL

Port protection made easier

  • Tegaderm I.V. Port Dressings application
  • Antimicrobial protection for patients with implanted venous ports

    Your patients go through tough treatments, and those with implanted venous ports are often faced with uncomfortable, ill-fitting dressings that don’t do enough to protect port sites. 3M Tegaderm I.V. Port Dressings are specifically designed for implanted venous ports, offering both antimicrobial protection and the comfort your patients deserve.

    Easy to remove – adhesive-free window minimises adhesive contact with non-coring needle and patient's skin, reducing the risk of the dressing sticking to needle during removal.


Catheter Securement device with the dressing

  • Sutureless securement device of PICC and CVC catheters

    Reliable securement of Peripherally Inserted Central Catheters (PICC) and Central Venous Catheters (CVC) is critical in avoiding the clinical and financial costs of complications. Traditional securement devices can be difficult and painful to apply and remove. Sutures can be uncomfortable for patients, and needlestick injuries can lead to significant burden on facilities and clinicians.

  • PICC/CVC Vascular access application

Antimicrobial dressing for Central Venous Catheters (CVC)

  • Tegaderm CHG Dressing application
  • Antimicrobial protection for patients with Central Venous Catheter

    3M Tegaderm CHG Chlorhexidine Gluconate I.V. Securement Dressing is designed for maximum protection for your oncology patients. It is the only transparent dressing cleared by the FDA to reduce catheter-related bloodstream infections (CRBSI) and vascular catheter colonisation, aligning with evidence-based guidelines and practice standards.

    Integrated I.V. dressing combines infection reduction with site visibility, catheter securement, and ease of use.


Antimicrobial dressing for peripheral I.V. catheters (PIV)

  • Help reduce the risk of PIV complications

    3M Tegaderm Antimicrobial I.V. Advanced Securement Dressing 9132 is an integrated I.V. dressing combining antimicrobial protection with site visibility, catheter securement and consistent application for peripheral I.V.

    Proven to suppress regrowth of skin flora for up to 7 days.²

    The dressing is specially designed for peripheral I.V. catheters.

     

  • tegaderm antimicrobial v advanced securement dressing

3M™ Curos™ Disinfecting Caps for Ports Protection

  • 3M™ Curos™ Disinfecting Port Protectors
  • Reducing the risk of bloodstream infections

    3M Curos Disinfecting Caps disinfect ports in 1 minute, and protects I.V. access points for up to 7 days if not removed.

    3M Curos Disinfecting Caps protectors are alcohol impregnated, provide fast passive disinfection and save nurses valuable time compared to most scrub the hub protocols.

    Brightly colored to help clinicians verify and measure compliance.

    Consistent use of 3M Curos Disinfecting Caps on I.V. needleless connectors is associated with decreased CLABSIs.


3M™ Cavilon™ No Sting Barrier Film

  • Proven to help protect your patient's skin.

    3M Cavilon No Sting Barrier Film forms a breathable, transparent, protective coating between the skin and the adhesive of the securement dressing, device or tape.

    3M Cavilon No Sting Barrier Film 1ml foam applicator 3343 is a gentle, effective, and CHG-compatible solution that protects skin of around vascular access sites and prevents damage from moisture.

  • Cavilon with Curos

We are committed to supporting you and your teams

Clinical Evidence banner

Meet the latest evidence data

We are proud to have a robust body of clinical evidence supporting the use of 3M Tegaderm CHG Chlorhexidine Gluconate I.V. Securement Dressing for antimicrobial protection, reduced risk of infection, ease of use and health economics.

Meet the latest evidence data

We are proud to have a robust body of clinical evidence supporting the use of 3M Tegaderm CHG Chlorhexidine Gluconate I.V. Securement Dressing for antimicrobial protection, reduced risk of infection, ease of use and health economics.

Get the free clinical evidence review

Effective and proven technology

Evidence-based solutions from 3M can help you protect patients, increase satisfaction and the reduce risk of costly complications — while delivering a high level of compassionate care.


  • Find the answers to the most frequently asked questions regarding 3M Health Care

    Go to FAQs

  • Join the 3M Health Care Academy and broaden your professional knowledge

    Find out more

  • If you have a question about a 3M Health Care product or service, please get in touch

    Contact us now

  • Find Instructions for Use (IFU) to easily access documents for specific 3M healtcare products.

References

  1. Böll B, Schalk E, Buchheidt D, et al. Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (Agiho) of the German Society of Hematology and Medical Oncology (Dgho). Ann Hematol. 2021;100(1):239-259.
  2. Bashir MH, Olson LK, Walters SA. Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin. Am J Infec Control. 2012;40:344–348.